Viewing Study NCT03906695

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:03 PM
Ignite Modification Date: 2026-01-14 @ 10:01 AM
Study NCT ID: NCT03906695
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-20
First Post: 2019-04-05
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase 1 Trial of ASTX727 in Subjects With Lower-risk Myelodysplastic Syndromes
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lower-risk Myelodysplastic View
Keywords: